Literature DB >> 2645931

Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study.

P A Frith1, V A Venning, F Wojnarowska, P R Millard, A J Bron.   

Abstract

Patients with bullous pemphigoid were found to have significant ocular abnormalities. In a group of 18 patients one had conjunctival shrinkage, and 11 of 15 (73%) had positive linear direct immunofluorescence on conjunctival biopsy from a clinically uninvolved site. Our ocular findings in a group of 14 with cicatricial pemphigoid are also reported and compared with those from a control group of 20. Our findings suggest there is overlap between the pemphigoid groups and raise further questions about the pathogenicity of immunoreactants within the basement membrane zone. Bulbar conjunctival biopsy was simple and well tolerated, and the rate of immunofluorescence positivity of conjunctiva was twice that of skin in both pemphigoid groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645931      PMCID: PMC1041643          DOI: 10.1136/bjo.73.1.52

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

2.  Enigma of ocular cicatricial pemphigoid. A comparative study of clinical and immunological findings.

Authors:  P Wright
Journal:  Trans Ophthalmol Soc U K       Date:  1979-04

3.  Benign mucous membrane pemphigoid. 3. Biopsy.

Authors:  S R Andersen; O A Jensen; E B Kristensen; M S Norn
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

4.  Oral lesions in bullous pemphigoid.

Authors:  G Shklar; I Meyer; S A Zacarian
Journal:  Arch Dermatol       Date:  1969-06

5.  Immunopathologic diagnosis of oral mucosal inflammatory diseases.

Authors:  R S Rogers; H M Van Hale
Journal:  Australas J Dermatol       Date:  1986-08       Impact factor: 2.875

6.  Immunologic aspects of cicatricial pemphigoid.

Authors:  B E Herron
Journal:  Am J Ophthalmol       Date:  1975-02       Impact factor: 5.258

7.  Ocular cicatricial pemphigoid (immunologic studies).

Authors:  S F Bean; N Furey; C E West; T Andrews; N B Esterly
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1976 Sep-Oct

8.  Immunofluorescent studies in mucous membrane pemphigoid.

Authors:  M R Griffith; K Fukuyama; D Tuffanelli; S Silverman
Journal:  Arch Dermatol       Date:  1974-02

Review 9.  Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations.

Authors:  J R Person; R S Rogers
Journal:  Mayo Clin Proc       Date:  1977-01       Impact factor: 7.616

10.  Immunopathology of oral mucosa in bullous pemphigoid.

Authors:  G Laskaris; G Nicolis
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1980-10
View more
  6 in total

1.  External ocular findings in lupus erythematosus: a clinical and immunopathological study.

Authors:  P Frith; S M Burge; P R Millard; F Wojnarowska
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

Review 2.  Autoimmune bullous dermatoses in the elderly: diagnosis and management.

Authors:  Diya F Mutasim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

3.  Triamcinolone acetonide for rare ocular manifestations of pemphigus vulgaris: a case report.

Authors:  N Kozeis; S Tyradellis; E Dragiotis; H Eleftheriadis
Journal:  Clin Ophthalmol       Date:  2010-04-26

4.  Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management.

Authors:  Diya F Mutasim
Journal:  Drugs Aging       Date:  2010-01-01       Impact factor: 3.923

5.  Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom.

Authors:  C F Radford; S Rauz; G P Williams; V P J Saw; J K G Dart
Journal:  Eye (Lond)       Date:  2012-06-22       Impact factor: 3.775

Review 6.  [Classification of ocular surface disease. Part 1].

Authors:  F E Kruse; C Cursiefen; B Seitz; H E Völcker; G O H Naumann; L Holbach
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.174

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.